Skip to main content
. Author manuscript; available in PMC: 2015 May 15.
Published in final edited form as: Behav Brain Res. 2014 Feb 28;265:171–180. doi: 10.1016/j.bbr.2014.02.033

Figure 5.

Figure 5

BMMNCs decrease white matter lesions in mid corpus callosum and corpus striatum of rats with 2VO. (A) Luxol fast blue staining of the middle of the corpus callosum on day 28 after treatment with BMMNCs. (B) Luxol fast blue staining of the corpus striatum on day 28 after treatment with BMMNCs. Scale bars in A and B = 30 μm. (C, D) Quantification of Luxol fast blue staining of the mid corpus callosum and corpus striatum shows that 2VO rats had less myelin than did sham groups. BMMNC transplantation significantly increased Luxol fast blue staining, but the effect was neutralized by SU5416. *p<0.01 vs. sham groups. #p<0.01 vs. the other three 2VO groups. n=6/group.